Jing-Tao Wu holds a Ph.D. in Chemistry from the University of Michigan and has worked at companies such as DuPont Pharmaceuticals, Millennium Pharmaceuticals and Takeda Pharmaceutical Company with roles of increasing responsibility in preclinical research and development.
He has published more than 50 peer-reviewed articles and served as program chair at several scientific conferences. He is currently senior vice president and head of early development at Alnylam Pharmaceuticals.